A new report from the association of the British Pharmaceutical Industry found "significant variation" in access to new medicines. The biggest variation was seen in the use of the medication for heart attacks and strokes.
Fewer than half of scotland's 14 territorial health boards prescribed GLP-1s for weight loss. More than 800 Scots have received the jabs for this purpose. The royal College of Physicians described lack of access to "safe and cost effective medicines"
A study looked at prescribing for non-statin low density lipoprotein medicines accepted by the SMC. The ABPI made seven recommendations including better planning and cooperation. More transparency by health boards about what medicines to use locally and how quickly accepted medicines are introduced.
This summary was written with AI assistance from the original article and may leave out important context. The original reporting belongs to BBC News · Health. Check the original, and official sources, before acting on any detail.